Source: Virtual Congress 2021 – COVID - 19: lessons learned



Rating:

Share or cite this content

Citations should be made in the following way:
B. Basina (Dnipropetrovsk, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), T. Kirieieva (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine), N. Kravhenko (Dnipro, Ukraine). Fibrinogen like the predictor of COVID-19 pneumonia progression. 517

Member's Comments

No comment yet.

Related content which might interest you: Severity, risk of progression or thrombosis – what does the D-dimer really reflect in COVID-19 pneumonia? Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019 Year: 2019 Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia. Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018 Platelet count as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Copeptin as a predictor of survival in ventilator associated pneumonia Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009 The best coagulation marker for prediction of COVID-19 pneumonia progression. Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 D-dimer is an independent marker predicting severity in community acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 What is the best biomarker of COVID-19 pneumonia progression? Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Lymphocyte-to-monocyte ratio (LMR) as a predictor of Covid-19 pneumonia progression Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Platelet-to-lymphocyte ratio (PLR) as a predictor of Covid-19 pneumonia progression Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Usefulness of procalcitonin as a predictor for bacteremia and prognosis in severe sepsis Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism Year: 2016 Neutrophil number, cytokine and elastase postoperative increase as probable pneumonia predictor Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 CRP as predictor as predictor for late treatment failure in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis Source: Eur Respir J , 49 (2) 1501924; DOI: 10.1183/13993003.01924-2015 Year: 2017 Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Source: Eur Respir J 2011; 37: 356 Year: 2011 BNP can be an all-cause mortality predictor in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Stable state fibrinogen is additive to MR-proADM as a predictor of mortality in COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD Source: Eur Respir J 2016; 47:1365-1373 Year: 2016 Thrombocytopenia as a predictor of mortality in pediatric community acquired pneumonia. Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017